324 related articles for article (PubMed ID: 24560125)
21. Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience.
Min GJ; Kim TY; Jeon YW; O JH; Choi BO; Park G; Park YH; Cho SG
Cancer Med; 2023 Apr; 12(7):7911-7922. PubMed ID: 36721307
[TBL] [Abstract][Full Text] [Related]
22. [Research progress in primary intraocular lymphoma].
Li M; Ye J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):795-800. PubMed ID: 26693776
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of primary central nervous system and primary intraocular lymphomas.
Tuaillon N; Chan CC
Curr Mol Med; 2001 May; 1(2):259-72. PubMed ID: 11899075
[TBL] [Abstract][Full Text] [Related]
25. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma.
Chan CC; Sen HN
Discov Med; 2013 Feb; 15(81):93-100. PubMed ID: 23449111
[TBL] [Abstract][Full Text] [Related]
26. Primary vitreoretinal lymphoma.
Kalogeropoulos D; Vartholomatos G; Mitra A; Elaraoud I; Ch'ng SW; Zikou A; Papoudou-Bai A; Moschos MM; Kanavaros P; Kalogeropoulos C
Saudi J Ophthalmol; 2019; 33(1):66-80. PubMed ID: 30930667
[TBL] [Abstract][Full Text] [Related]
27. Management of primary intraocular lymphoma.
Kim SK; Chan CC; Wallace DJ
Curr Oncol Rep; 2005 Jan; 7(1):74-9. PubMed ID: 15610690
[TBL] [Abstract][Full Text] [Related]
28. Primary intraocular lymphoma: A review.
Choi JY; Kafkala C; Foster CS
Semin Ophthalmol; 2006; 21(3):125-33. PubMed ID: 16912010
[TBL] [Abstract][Full Text] [Related]
29. Primary intraocular lymphoma: improving the diagnostic procedure.
Karma A; von Willebrand EO; Tommila PV; Paetau AE; Oskala PS; Immonen IJ
Ophthalmology; 2007 Jul; 114(7):1372-7. PubMed ID: 17324466
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
[TBL] [Abstract][Full Text] [Related]
31. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
[TBL] [Abstract][Full Text] [Related]
32. Intraocular Lymphoma Masquerading as Recurrent Iridocyclitis: Findings Based on in vivo Confocal Microscopy.
Zhang P; Tian J; Gao L
Ocul Immunol Inflamm; 2018; 26(3):362-364. PubMed ID: 29099641
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of primary intraocular lymphoma: an update.
Jahnke K; Thiel E; Abrey LE; Neuwelt EA; Korfel A
Clin Ophthalmol; 2007 Sep; 1(3):247-58. PubMed ID: 19668478
[TBL] [Abstract][Full Text] [Related]
34. Clinical review: treatment of vitreoretinal lymphoma.
Pe'er J; Hochberg FH; Foster CS
Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy of primary intraocular lymphoma associated with primary central nervous system lymphoma.
Tropinskaya OF; Vetlova ER; Serova NK; Golanov AV; Fil'chenkova NA
Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(3):74-81. PubMed ID: 27296540
[TBL] [Abstract][Full Text] [Related]
36. Primary CNS lymphoma.
Touitou V; LeHoang P; Bodaghi B
Curr Opin Ophthalmol; 2015 Nov; 26(6):526-33. PubMed ID: 26367092
[TBL] [Abstract][Full Text] [Related]
37. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
38. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
39. [Relapsed primary intraocular lymphoma treated with intravitreal methotrexate and high-dose chemotherapy followed by autologous stem cell rescue].
Kamio T; Yokohama A; Hayashi T; Toyama K; Koya H; Hoshino T; Saitoh T; Hanyuda N; Mukai R; Handa H; Murakami H; Tsukamoto N; Nojima Y
Rinsho Ketsueki; 2014 Feb; 55(2):244-8. PubMed ID: 24598193
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteria.
Siegal T
J Clin Neurosci; 2014 May; 21(5):709-15. PubMed ID: 24725453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
